NCT01476137
- Conditions
- Blood Protein Disorders, Cancer, Cardiovascular Diseases, +13 more
- Locations
-
- GSK Investigational Site Dallas, Texas, United States
- GSK Investigational Site San Antonio, Texas, United States
Clinical trial condition
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
NCT01476137
NCT02046915
NCT01764880
NCT00871910
Not specified
NCT00899847
NCT00006184
NCT00056160
NCT01660750
NCT00081939